
Norglim-MF 1 Tablet SR
Marketer
Curelife Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Norglim-MF 1 Tablet SR
DiabetaComb-1 SR, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two glucose-regulating agents to maintain healthy blood sugar levels. DiabetaComb-1 SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose readings. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. DiabetaComb-1 SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is vital, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Norglim-MF 1 Tablet SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Norglim-MF 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Norglim-MF 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Norglim-MF 1 Tablet SR with a meal.
Common Side effects of Norglim-MF 1 Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Norglim-MF 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Norglim-MF 1 Tablet SR with a meal.
How Norglim-MF 1 Tablet SR works:
Norglim-MF SR, a single-tablet formulation, combines the antihyperglycemic agents glimepiride and metformin. Glimepiride, a sulfonylurea derivative, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose output, slowing intestinal glucose absorption, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Norglim-MF 1 Tablet SR ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Norglim-MF 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Sustained-release Norglim-MF tablets (1mg) are contraindicated during lactation. Evidence indicates potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Norglim-MF 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Norglim-MF 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Norglim-MF 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Norglim-MF 1 Tablet SR therapy at a reduced dosage. Its use is contraindicated in patients with severe liver disease.
What if you forget to take Norglim-MF 1 Tablet SR :
Should you forget a dose of Norglim-MF 1 Tablet SR, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Norglim-MF 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
